Sign In
NewsRadar

AC Immune

AC Immune focuses on the development of therapies against Alzheimer's disease. It is using its immunology platform to develop active and passive immunotherapies, i.e. vaccine and monoclonal antibodies, directly reducing the toxic ss-amyloid plaques in the brain.

• Show past press releases
• Edit this company

Contact Information
Address:
 
 
Phone:
Fax:
Web:
Contact:
 
 
PSE Building B - EPFL
Lausanne CH-1015
Switzerland
+41 21 693 91 21
+41 21 693 91 20
http://www.acimmune.com
Andrea Pfeifer
+(41)21-693-91-22

Company Facts
Founded:Feb 2003
Founders:
CEO:Andrea Pfeifer
CTO or technical lead:
CFO or finance director:
Head of Sales:
Head of Marketing:

Stage:
Category:Biotechnology & Healthcare
Sector:Biopharmaceuticals
Employees:
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:

Non-executive Board Members

Key Customers

Key Business Partners

Key Competitors

Capital Raised
DateSizeInvestors
To view this information you must be signed in and subscribed to the online dataservice, sign in here.

To read more about the Online data service click here

Public Offerings
DateTypeExchange
No public offerings


Data


26,807
Tech investments
From our Online Data Service
17,301
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Nov 25€24.0MInternet commerce
Mar 23€2.0MInternet services
Mar 23€1.5MInternet services
Mar 23€110.0MInternet commerce
Mar 21€1.9MBusiness applications
Mar 20€1.0MInternet commerce
Mar 20€12.0ME-Commerce

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Jan 29
Yumpingo
yumpingo raises $10m to transform guest experiences in restaurants

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase





About usContact usLegal Information
Copyright 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.